UNICALCIN 50IU INJECTION

Unicalcin 50IU Injection is a source of an active ingredient known as Calcitonin. This hormone is involved in the regulation of calcium throughout the body. The thyroid gland is the primary source of it and assists in lowering blood calcium levels by preventing bone calcium release and increasing excretion through the kidneys. In the medical field, synthetic versions are utilized for treating specific ailments. The drug treats postmenopausal bone loss, Paget’s Disease (type of bone disease) and hypercalcemia. It also helps prevent bone loss in people who suffer from fractures. It helps strengthen the bone and helps prevent further injury. Unicalcin 50IU injection can ease pain in the bones of cancer patients whose cancer has spread into the bones.
This medicine is not recommended for people with a history of allergic reactions or hypersensitivity in the presence of Unicalcin 50IU injection or other constituents. The allergic reaction could manifest as skin eruptions, itching, swelling or breathing difficulties. This medication can reduce blood calcium levels. Therefore, it shouldn’t be given to people with low calcium levels (hypocalcemia). Patients with impaired kidney function might require dosage adjustments because the kidneys process the medication. Close monitoring is necessary to ensure that there is no accumulation of the drug. Unicalcin 50IU injection can cause digestive side effects, such as nausea or vomiting.